Suppr超能文献

[多发性硬化症中的葡萄膜炎:概述与展望]

[Uveitis in multiple sclerosis : Overview and perspectives].

作者信息

Hildebrandt A L, Mackensen F

机构信息

Interdisziplinäres Uveitiszentrum, Universitäts-Augenklinik, Ruprecht-Karls-Universität, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland.

出版信息

Ophthalmologe. 2014 Aug;111(8):733-9. doi: 10.1007/s00347-013-2984-x.

Abstract

The association of uveitis and multiple sclerosis (MS) is less well known than the association between optic neuritis and MS even though MS patients suffer ten times more often from uveitis than the normal population. In this group of patients, intermediate uveitis presenting with periphlebitis and "snowbanks" or "snowballs", as well as granulomatous anterior uveitis play an important role. Simultaneous occurrence of MS and uveitis could be due to the fact that both neural and ocular tissues have the same embryological origin or could be the consequence of an immunological reaction following an Epstein-Barr virus infection. The aim is to find a drug for these patients that treats both MS and uveitis. Currently various studies with different drugs already used successfully in MS patients are under investigation for use in the treatment of uveitis. There is some evidence that interferon beta is effective in macular edema associated with uveitis. Other substances, such as daclizumab, natalizumab and fingolimod also seem to be promising.

摘要

葡萄膜炎与多发性硬化症(MS)之间的关联不如视神经炎与MS之间的关联那么广为人知,尽管MS患者患葡萄膜炎的几率是正常人群的十倍。在这组患者中,伴有静脉周围炎和“雪堤”或“雪球”的中间葡萄膜炎以及肉芽肿性前葡萄膜炎起着重要作用。MS和葡萄膜炎同时出现可能是因为神经组织和眼组织具有相同的胚胎学起源,也可能是爱泼斯坦-巴尔病毒感染后免疫反应的结果。目标是为这些患者找到一种既能治疗MS又能治疗葡萄膜炎的药物。目前,针对已在MS患者中成功使用的不同药物进行的各种研究正在进行,以用于治疗葡萄膜炎。有证据表明,β-干扰素对与葡萄膜炎相关的黄斑水肿有效。其他物质,如达利珠单抗、那他珠单抗和芬戈莫德似乎也很有前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验